Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Avalo Therapeutics, Inc./ EFFECT

SEC Filing · EFFECT

Avalo Therapeutics, Inc.

AVTXNASDAQEQUITYCurrent

SEC Filing

Filed Jul 28, 2026Accepted Jul 29, 2026, 12:15 AM EDTCIK 1534120Accession 9999999995-26-002480
View company →Permanent SEC source ↗
Share

Company context

Current securities

AVTXNASDAQ · EQUITY · Current
Historical securities (2)
CERCWNASDAQ · WARRANT · Historical · closed Oct 18, 2018CERCZNASDAQ · WARRANT · Historical · closed Apr 18, 2017

Recent company filings

  1. 144 filingAug 17, 2026
  2. SCHEDULE 13G/A filingAug 14, 2026
  3. SCHEDULE 13G/A filingAug 14, 2026
  4. SCHEDULE 13G/A filingAug 14, 2026
  5. SCHEDULE 13G/A filingAug 14, 2026

As-filed source

Primary evidence
As filedOpen full document ↗